| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/27/2006 | WO2006042826A1 Method for the combined isolation of magnet-beads from a liquid sample and subsequent thermocyclisation for the polymerase chain reaction (pcr) and associated arrangement |
| 04/27/2006 | WO2006042811A2 A sensor film for transcutaneous insertion and a method for making the sensor film |
| 04/27/2006 | WO2006042745A2 Chemically modified peptide analogs |
| 04/27/2006 | WO2006042524A1 Rapid measurement of large path differences in birefringent materials without and with false colours |
| 04/27/2006 | WO2006042520A1 Ultrasound method for determination of parameters and/or the homogeneity of an open-pored material layer |
| 04/27/2006 | WO2006042411A1 Method and system for detecting characteristics of lumber using end scanning |
| 04/27/2006 | WO2006042369A1 Analytical method and apparatus |
| 04/27/2006 | WO2006033972A9 Protein arrays and methods of use thereof |
| 04/27/2006 | WO2006027545A3 Method |
| 04/27/2006 | WO2006022550A3 Gas monitor |
| 04/27/2006 | WO2006021345A3 Diagnostics and therapeutics for diseases associated with adrenergic alpha-1b receptor (adra1b) |
| 04/27/2006 | WO2006020931A3 Process for removing endogenous vitamin b12 and folate from albumin preparations |
| 04/27/2006 | WO2006013474A8 Ppgalnac-t6 mrna or peptide as a new marker for detection cancer cells |
| 04/27/2006 | WO2006012614A3 Fabrication methods and multifunctional substrate materials for chemical and biological analysis in microfluidic systems |
| 04/27/2006 | WO2006010489A3 Diagnostics and therapeutics for diseases associated with choline kinase like protein (chkl) |
| 04/27/2006 | WO2006009435A3 Method for detecting and measuring a ligand |
| 04/27/2006 | WO2006005940A3 Monoclonal anti-glut2 antibody |
| 04/27/2006 | WO2006003423A3 Gel formulations and uses thereof |
| 04/27/2006 | WO2005124361A3 Uses of gpr100 receptor in diabetes and obesity regulation |
| 04/27/2006 | WO2005124337A3 Methods of identifying and/or obtaining a compound which modulates the citrullination of histone h3 |
| 04/27/2006 | WO2005121796A3 Method for detecting alzheimer’s disease and other forms of dementia, and measuring their progression |
| 04/27/2006 | WO2005121786A3 Brca1 markers |
| 04/27/2006 | WO2005121759A3 Device and method for analyte measurement |
| 04/27/2006 | WO2005121363A3 Method for determining biophysical properties |
| 04/27/2006 | WO2005116660A3 Methods for making and using mass tag standards for quantitative proteomics |
| 04/27/2006 | WO2005115459A3 Anti-viral activity of an anti-thymidine kinase monoclonal antibody |
| 04/27/2006 | WO2005114207A3 Diagnostics and therapeutics for diseases associated with aminopeptidase n (anpep) |
| 04/27/2006 | WO2005114197A3 Activity-based probes for protein tyrosine phosphatases |
| 04/27/2006 | WO2005113586A3 Disease-associated proteins |
| 04/27/2006 | WO2005111622A3 Diagnostic assay for trypanosoma cruzi infection |
| 04/27/2006 | WO2005108613A3 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 04/27/2006 | WO2005108427A3 Method for producing soluble mhc proteins |
| 04/27/2006 | WO2005103723A3 Method for the diagnosis of chronic stress and related disorders |
| 04/27/2006 | WO2005103705A3 Chemoselective fluorogenic molecular linkers and methods of their preparation and use |
| 04/27/2006 | WO2005101019A3 Detection of nitrosylated proteins |
| 04/27/2006 | WO2005101009A3 Diagnostics and therapeutics for diseases associated with tachykinin receptor 2 (tacr2) |
| 04/27/2006 | WO2005101004A3 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 04/27/2006 | WO2005100599A3 Cyclic voltammetry (cv) for identifying genomic sequence variations and detecting mismatch base pairs, such as single nucleotide polymorphisms |
| 04/27/2006 | WO2005100390A3 Bob-1 specific t cells and methods to use |
| 04/27/2006 | WO2005095636A3 Methods for measuring enzyme activities in cells, blood, tumors and tissues |
| 04/27/2006 | WO2005095457A3 Immunoglobulins |
| 04/27/2006 | WO2005094348A3 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 04/27/2006 | WO2005087792A3 Materials and methods relating to the treatment of glioblastomas |
| 04/27/2006 | WO2005085285A3 Nuclear hormone receptors |
| 04/27/2006 | WO2005076010A3 Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential |
| 04/27/2006 | WO2005059110A3 Methods and materials for canine breed identification |
| 04/27/2006 | WO2005054871A3 Analysis of mass spectral data in the quiet zones |
| 04/27/2006 | WO2005049789A3 Synthetic mammalian retrotransposon gene |
| 04/27/2006 | WO2005045057A3 Methods for diagnosing bipolar and unipolar disorder |
| 04/27/2006 | WO2005040409A3 Method for diagnosis of rheumatic diseases and agents for carrying out said diagnosis |
| 04/27/2006 | WO2005039397A3 Methods of diagnosing tissue fibrosis |
| 04/27/2006 | WO2005032350A3 Determinationof phenotype of cancer and of precancerous tissue |
| 04/27/2006 | WO2005029619A8 Methods and apparatus for breath alcohol testing |
| 04/27/2006 | WO2005021582A3 Methods for the early diagnosis of ovarian cancer |
| 04/27/2006 | WO2005017659A3 Software system for zero emergency assessment of airborn, chemical, biological, radiological (cbr) threats |
| 04/27/2006 | WO2005005601A3 Compositions and methods for treating and diagnosing cancer |
| 04/27/2006 | WO2004105773A3 Use of s1p |
| 04/27/2006 | WO2004078035A3 Expression profiles for breast cancer and methods of use |
| 04/27/2006 | WO2004005486A3 Mp21s as modifiers of the p21 pathway and methods of use |
| 04/27/2006 | WO2004001064A3 Serum protein-associated target-specific ligands and identification method therefor |
| 04/27/2006 | US20060089825 Scanning kelvin microprobe system and process for biomolecule microassay |
| 04/27/2006 | US20060089810 Biological sample analyzing apparatus and biological sample analyzing method |
| 04/27/2006 | US20060089808 Conformational sampling by self-organization |
| 04/27/2006 | US20060089807 Identifying peptide modifications |
| 04/27/2006 | US20060089493 Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas |
| 04/27/2006 | US20060089401 Kinase inhibitors |
| 04/27/2006 | US20060089320 Modulation of type IIß phosphoinositide phosphate kinase |
| 04/27/2006 | US20060089311 Agonists and antagonists of ryzn for the treatment of metabolic disorders |
| 04/27/2006 | US20060089303 Cancer-testis antigens |
| 04/27/2006 | US20060089302 Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases |
| 04/27/2006 | US20060089297 Sperm specific lysozyme-like proteins |
| 04/27/2006 | US20060088946 Optical microlabels: shapes and reflectors |
| 04/27/2006 | US20060088945 Electrochemical test device and related methods |
| 04/27/2006 | US20060088943 Method and apparatus for determining a concentration of a component in a mixture |
| 04/27/2006 | US20060088942 Measuring nitric oxide in blood gases and treatments based thereon |
| 04/27/2006 | US20060088941 Method and apparatus for measuring white blood cell count |
| 04/27/2006 | US20060088939 Methods for analysis of soil samples |
| 04/27/2006 | US20060088933 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay |
| 04/27/2006 | US20060088915 A G protein-coupled receptor protein for the treatment of digestive diseases |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088908 Mutiens of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/27/2006 | US20060088897 Modulators |
| 04/27/2006 | US20060088896 Diagnostic device for rapid determination of buprenorphine |
| 04/27/2006 | US20060088895 Systems, methods and reagents for the detection of biological and chemical agents using dynamic surface generation and imaging |
| 04/27/2006 | US20060088894 Prostate cancer biomarkers |
| 04/27/2006 | US20060088893 Prostate cancer therapeutics and diagnostics based on conformers of prostatic cid phosphatase |
| 04/27/2006 | US20060088892 Detection of Trichomonas |
| 04/27/2006 | US20060088891 Bioassay of measuring tyrosine-kinase ligand, tumor necrosis factor and transforming growth factor level, before administering the myelosuppressive agent to the patient; use in optimizing treatment and avoiding toxic effects |
| 04/27/2006 | US20060088890 Identification and isolation of somatic stem cells and uses thereof |
| 04/27/2006 | US20060088888 Methods of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity |
| 04/27/2006 | US20060088887 Method for screening substance which can bind to receptor |
| 04/27/2006 | US20060088886 Topiramate analogs |
| 04/27/2006 | US20060088885 Immunoassays for topiramate |
| 04/27/2006 | US20060088884 Administering brain-derived neurotrophic factor in its native sequence to an oocyte; stimulation of oocyte maturation alleviates an infertility condition |
| 04/27/2006 | US20060088881 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 molecules |
| 04/27/2006 | US20060088880 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 04/27/2006 | US20060088877 Systematic evolution of ligands by exponential enrichment: Chemi-SELEX |
| 04/27/2006 | US20060088860 Metabolite markers for weight management |
| 04/27/2006 | US20060088852 Method for determining the homeostasis of hairy skin |
| 04/27/2006 | US20060088851 Invasion/migration gene |